Viewing Study NCT04243434


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-02-26 @ 4:14 AM
Study NCT ID: NCT04243434
Status: UNKNOWN
Last Update Posted: 2020-04-16
First Post: 2019-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Sponsor: Acrotech Biopharma Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SPI-MAR-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View